31396 Tirzepatide for Sale
Compare supplier listings for Tirzepatide (CAS 2023788-19-2) — check price, grade and packaging, then open a product page or send an inquiry. View Suppliers
Tirzepatide CAS 2023788-19-2 API powder weight loss TR5 TR10 10MG 20MG
-
Price:
$50/UNIT FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
10mg/vial, 10vials/box
Tirzepatide CAS 2023788-19-2 API powder weight loss OEM / private label customization available
-
Price:
$50/UNIT FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
10mg/vial, 10vials/box
high quality Top Quality Peptides Lyophilized Powder Tirzepatide Fitness and Weight Loss
-
Price:
$50/UNIT FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
10 vials/box
Tirzepatide CAS 2023788-19-2 API powder weight loss PEPTIDE Lyophilized Powder
-
Price:
$30/UNIT FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
10mg/vial, 10vials/box
Low prices Tirzepatide CAS 2023788-19-2 API powder weight loss PEPTIDE Peptide suppliers
-
Price:
$30/UNIT FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
10mg/vial, 10vials/box
Products You May Be Interested in
- 2-Piperidinecarboxylic acid, 5-[(phenylmethoxy)amino]-, phenylmethyl ester, (2S,5R)-, ethanedioate (1:1) for sale
- tert-butyl2,4-dioxopyrrolidine-1-carboxylate for sale
- 2-Hydroxy-3-phenoxypropyl acrylate for sale
- N-(2-Chlorophenyl)-3-oxobutanamide for sale
- Methyl 4-amino-3-(benzyloxy)-5-bromobenzenecarboxylate for sale
Weight Management Peptide Tirzepatide CAS 2023788-19-2 API powder weight loss PEPTIDE
-
Price:
$30/UNIT FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
10mg/vial, 10vials/box
Bulk Supply CAS 2023788-19-2 Tirzepatide API powder weight loss PEPTIDE TR10 TR20 TR30 TR50
-
Price:
$30/UNIT FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
10mg/vial, 10vials/box
Peptide suppliers Tirzepatide CAS 2023788-19-2 API weight loss PEPTIDE TR5 TR10 TR20 TR30 TR40 TR50 TR60
-
Price:
$30/UNIT FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
10mg/vial, 10vials/box
BUY ARA-290 Lyophilized Peptides 99% High Purity CAS 1208243-50-8 Cosmetic Grade10mg Vials/box
-
Price:
$40/UNIT FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
10mg/vial, 10vials/box
Bulk Supply TR5 TR10 TR15 TR20 TR30 TR40 TR50 TR60 Tirzepatide weight loss Secure Packaging & Fast Delivery
-
Price:
$35/UNIT FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
10Vials/box
- Buying Tirzepatide on www.echemi.com where you will find large variety of good choices. Suppliers of 31396 Tirzepatide registered will be verified by the accurate information. Safe transaction of chemical will be made based on true information. We help you get chemicals in need continuously and meet registered Tirzepatide suppliers.
- The quality of Tirzepatide 2023788-19-2 will be secured by ECHEMI. The pursuit of high quality requires all partners of ECHEMI to be screened, whether its certificate, qualification or scale. Tirzepatide will reach global regulation and requirement of various regions. Further services on the whole supply chain can be provided with ECHEMI.
- We offer reasonable and fair market price of Tirzepatide to provide better products and services. Services of Tirzepatide like trade data and market price and insight can be subscribed on ECHEMI. You can enjoy the chemical supply chain services on ECHEMI. We will help you purchase Tirzepatide and run fast your business.
- •China’s Hybio Takes Generic Tirzepatide to FDA: Lilly’s GLP-1 Fortress Gets a Warning Shot
- •Cipla CEO Calls Tirzepatide a High-Science Product with Strong Market Outlook
- •Novo Nordisk’s Semaglutide Faces Strong Competition: Eli Lilly’s Tirzepatide Officially Launched in China
- •Eli Lilly Revenue Reaches $31.5 Billion, Up 27%! Tirzepatide and Semaglutide Exceed $20 Billion
- •Novo Nordisk's 2024 Earnings Surge by 23%! Diabetes Drug Sales Skyrocket, but Facing Competition Pressure from Tirzepatide